- Home
- FEBO vs BFRI Comparison
FEBO vs BFRI Comparison
Compare FEBO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEBO
- BFRI
- Stock Information
- Founded
- FEBO 1993
- BFRI 1997
- Country
- FEBO Hong Kong
- BFRI United States
- Employees
- FEBO N/A
- BFRI N/A
- Industry
- FEBO
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- FEBO
- BFRI Health Care
- Exchange
- FEBO Nasdaq
- BFRI Nasdaq
- Market Cap
- FEBO 8.0M
- BFRI 7.9M
- IPO Year
- FEBO 2023
- BFRI 2021
- Fundamental
- Price
- FEBO $0.76
- BFRI $0.85
- Analyst Decision
- FEBO
- BFRI Strong Buy
- Analyst Count
- FEBO 0
- BFRI 1
- Target Price
- FEBO N/A
- BFRI $2.75
- AVG Volume (30 Days)
- FEBO 444.4K
- BFRI 367.7K
- Earning Date
- FEBO 10-24-2025
- BFRI 11-12-2025
- Dividend Yield
- FEBO N/A
- BFRI N/A
- EPS Growth
- FEBO N/A
- BFRI N/A
- EPS
- FEBO N/A
- BFRI N/A
- Revenue
- FEBO $17,110,653.00
- BFRI $39,188,000.00
- Revenue This Year
- FEBO N/A
- BFRI $11.07
- Revenue Next Year
- FEBO N/A
- BFRI $11.20
- P/E Ratio
- FEBO N/A
- BFRI N/A
- Revenue Growth
- FEBO 11.58
- BFRI 11.20
- 52 Week Low
- FEBO $0.61
- BFRI $0.54
- 52 Week High
- FEBO $7.26
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- FEBO 48.67
- BFRI 46.65
- Support Level
- FEBO $0.75
- BFRI $0.81
- Resistance Level
- FEBO $0.84
- BFRI $0.86
- Average True Range (ATR)
- FEBO 0.06
- BFRI 0.05
- MACD
- FEBO 0.02
- BFRI -0.00
- Stochastic Oscillator
- FEBO 54.77
- BFRI 34.93
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.